# Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in Patients With ARDS

> **NCT05241067** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Pharmazz, Inc.** · enrollment: 80 (estimated)

## Conditions studied

- Acute Respiratory Distress Syndrome (ARDS)

## Interventions

- **DRUG:** Normal Saline
- **DRUG:** Centhaquine

## Key facts

- **NCT ID:** NCT05241067
- **Lead sponsor:** Pharmazz, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2026-10-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05241067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05241067, "Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in Patients With ARDS". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05241067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*